127 related articles for article (PubMed ID: 4128550)
1. Deamination of 5-azacytidine by a human leukemia cell cytidine deaminase.
Chabner BA; Drake JC; Johns DG
Biochem Pharmacol; 1973 Nov; 22(21):2763-5. PubMed ID: 4128550
[No Abstract] [Full Text] [Related]
2. Purification and properties of cytidine deaminase from normal and leukemic granulocytes.
Chabner BA; Johns DG; Coleman CN; Drake JC; Evans WH
J Clin Invest; 1974 Mar; 53(3):922-31. PubMed ID: 4521417
[TBL] [Abstract][Full Text] [Related]
3. Resistance of cyclocytidine to cytidine deaminase.
Hoshi A; Iigo M; Saneyoshi M; Kuretani K
Chem Pharm Bull (Tokyo); 1973 Jul; 21(7):1535-8. PubMed ID: 4731230
[No Abstract] [Full Text] [Related]
4. Distribution of kinase and deaminase of 1-beta-D-arabinofuranosylcytosine in tissues of man and mouse.
Ho DH
Cancer Res; 1973 Nov; 33(11):2816-20. PubMed ID: 4518302
[No Abstract] [Full Text] [Related]
5. Potent inhibitors for the deamination of cytosine arabinoside and 5-aza-2'-deoxycytidine by human cytidine deaminase.
Laliberté J; Marquez VE; Momparler RL
Cancer Chemother Pharmacol; 1992; 30(1):7-11. PubMed ID: 1375134
[TBL] [Abstract][Full Text] [Related]
6. Enzymatic studies on possible improvement of cytosine arabinoside treatment.
Mejer J
Scand J Clin Lab Invest; 1981 Feb; 41(1):29-34. PubMed ID: 6942484
[TBL] [Abstract][Full Text] [Related]
7. A new deoxycytidine analog, 5-hydroxy-2'-deoxycytidine.
Leung KK; Visser DW
Biochem Med; 1974 Mar; 9(3):237-43. PubMed ID: 4596958
[No Abstract] [Full Text] [Related]
8. Biochemical pharmacology of cytidine analog metabolism in human leukemic cells.
Stoller RG; Coleman CN; Chang P; Hande KR; Chabner BA
Bibl Haematol; 1975 Oct; (43):531-3. PubMed ID: 61003
[No Abstract] [Full Text] [Related]
9. Kinetics of deamination of 5-aza-2'-deoxycytidine and cytosine arabinoside by human liver cytidine deaminase and its inhibition by 3-deazauridine, thymidine or uracil arabinoside.
Chabot GG; Bouchard J; Momparler RL
Biochem Pharmacol; 1983 Apr; 32(7):1327-8. PubMed ID: 6189497
[No Abstract] [Full Text] [Related]
10. In vitro-in vivo correlation of drug metabolism--deamination of 1- -D-arabinofuranosylcytosine.
Dedrick RL; Forrester DD; Ho DH
Biochem Pharmacol; 1972 Jan; 21(1):1-16. PubMed ID: 4500983
[No Abstract] [Full Text] [Related]
11. Studies of the enzymatic deamination of cytosine arabinoside. 3. Substrate requirements and inhibitors of the deaminase of human liver.
Camiener GW
Biochem Pharmacol; 1967 Sep; 16(9):1691-702. PubMed ID: 6061556
[No Abstract] [Full Text] [Related]
12. Comparative studies of the cytostatic action and metabolism of 5-azacytidine and 5,6-dihydro-5-azacytidine.
Voytek P; Beisler JA; Abbasi MM; Wolpert-DeFilippes MK
Cancer Res; 1977 Jul; 37(7 Pt 1):1956-61. PubMed ID: 67884
[TBL] [Abstract][Full Text] [Related]
13. Enzymatic studies on possible improvement of cytosine arabinoside treatment.
Mejer J
Scand J Clin Lab Invest; 1982 Sep; 42(5):401-6. PubMed ID: 6961505
[TBL] [Abstract][Full Text] [Related]
14. [Comparative study of lysozymes from leucocytes of normal persons and of patients with chronic myelogenous leukaemia].
Périn JP; Jollès P
Clin Chim Acta; 1972 Nov; 42(1):77-84. PubMed ID: 4511159
[No Abstract] [Full Text] [Related]
15. Cellular phosphorylation of 1-beta-D-arabinofuranosylcytosine 5-azacytidine with intact fibrosarcoma and leukemic cells.
Lee T; Karon M; Monparler RL
Cancer Res; 1975 Sep; 35(9):2506-10. PubMed ID: 50132
[TBL] [Abstract][Full Text] [Related]
16. The equilibrium of hydrolytic deamination of cytidine and N 4 -methylcytidine.
Cohen RM; Wolfenden R
J Biol Chem; 1971 Dec; 246(24):7566-8. PubMed ID: 4944312
[No Abstract] [Full Text] [Related]
17. Cytidine deaminase - the methodological relevance of AraC deamination for ex vivo experiments using cultured cell lines, fresh leukemic blasts, and normal bone marrow cells.
Braess J; Pförtner J; Kern W; Hiddemann W; Schleyer E
Ann Hematol; 1999 Nov; 78(11):514-20. PubMed ID: 10602895
[TBL] [Abstract][Full Text] [Related]
18. Studies on nucleoside deaminase. Increase in activity in HeLa cell cultures caused by cytosine arabinoside.
Meyers R; Malathi VG; Cox RP; Silber R
J Biol Chem; 1973 Sep; 248(17):5909-13. PubMed ID: 4726293
[No Abstract] [Full Text] [Related]
19. Metabolism of 4-N-hydroxy-cytidine in Escherichia coli.
Trimble RB; Maley F
J Bacteriol; 1971 Oct; 108(1):145-53. PubMed ID: 4941553
[TBL] [Abstract][Full Text] [Related]
20. Studies on the cytostatic action, phosphorylation and deamination of 5-azacytidine and 5,6-dihydro-5-azacytidine in HeLa cells.
Futterman B; Derr J; Beisler JA; Abbasi MM; Voytek P
Biochem Pharmacol; 1978 Mar; 27(6):907-9. PubMed ID: 77670
[No Abstract] [Full Text] [Related]
[Next] [New Search]
